Response to Comment on Gange et al. Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes. Diabetes Care 2021;44:2518 –2526

We appreciate the comments made by Rigalleau et al. (1) and their interest in our article (2), which quantified the incidence of proliferative diabetic retinopathy (PDR) and other neovascular complications within the first 5 years following an index diagnosis of type 2 diabetes. Further, we identified risk factors for developing PDR within 5 years of being diagnosed with type 2 diabetes, including hemoglobin A1c (HbA1c), renal disease, peripheral circulatory disorders, neurological disease, and older age. As has been previously reported, the diagnosis of type 2 diabetes may be delayed relative to its onset.
Source: Diabetes Care - Category: Endocrinology Source Type: research